Altamira Therapeutics Ltd. (CYTO)
USD 0.3
(0.0%)
USD 0.3
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -11.51 Million | -8.68 Million | -13.67 Million | -4.84 Million | -8.39 Million | -13.23 Million |
| Net Income | -3.86 Million | -26.52 Million | -17.39 Million | -8.2 Million | -6.63 Million | -11.49 Million |
| Depreciation & Amortization | 119.3 Thousand | 118.88 Thousand | 76.35 Thousand | 20.03 Thousand | 30.82 Thousand | 72.71 Thousand |
| Deferred income taxes | -99.84 Thousand | -10.32 Thousand | 21.62 Thousand | -21.28 Thousand | -193.83 Thousand | 162.17 Thousand |
| Stock-based compensation | 379.41 Thousand | 342.79 Thousand | 1.2 Million | 368.79 Thousand | 226.6 Thousand | 27.73 Thousand |
| Change in working capital | -4.24 Million | 3.55 Million | 511.11 Thousand | 300.52 Thousand | -1.22 Million | -2.47 Million |
| Other non-cash items | -3.79 Million | 13.83 Million | 1.9 Million | 2.68 Million | -601.08 Thousand | 474.69 Thousand |
| Investing Cash Flow | 1.44 Million | -2.14 Million | -3.5 Million | -2.31 Million | -3 Million | -1.82 Million |
| Investments in PPE | - | -2.14 Million | -3.32 Million | -2.31 Million | -3.01 Million | -1.89 Million |
| Acquisitions | 1.43 Million | - | - | - | - | - |
| Investment purchases | - | - | -179.1 Thousand | - | - | - |
| Sales/Maturities of investments | 10.04 Thousand | - | - | - | - | - |
| Other Investing Activities | 505.00 | 969.00 | -179.1 Thousand | 258.00 | 17.88 Thousand | 68.16 Thousand |
| Financing Cash Flow | 10.62 Million | 9.83 Million | 6.61 Million | 16.96 Million | 7.37 Million | 5.73 Million |
| Debt repayment | -1.45 Million | -114.25 Thousand | -68.7 Thousand | -1.52 Million | -1.46 Million | -9.27 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | 9.79 Million | 17.44 Million |
| Other Financing Activities | -786.29 Thousand | 9.94 Million | 6.68 Million | 16.96 Million | -952.36 Thousand | -2.44 Million |
| Accounts receivables | 14.06 Thousand | -103.6 Thousand | -340.11 Thousand | 254.43 Thousand | -18.92 Thousand | -18.39 Thousand |
| Accounts payables | -14.06 Thousand | 103.6 Thousand | 340.11 Thousand | - | - | - |
| Inventory | -319.82 Thousand | 827.57 Thousand | -839.22 Thousand | - | - | - |
| Other working capital | -3.92 Million | 2.73 Million | 1.35 Million | 46.08 Thousand | -1.2 Million | -3.09 Million |
| Cash at beginning of period | 15.39 Thousand | 984.19 Thousand | 11.25 Million | 1.38 Million | 5.39 Million | 14.97 Million |
| Cash at end of period | 617.4 Thousand | 15.39 Thousand | 984.19 Thousand | 11.25 Million | 1.38 Million | 5.39 Million |
| Capital Expenditure | - | -2.14 Million | -3.32 Million | -2.31 Million | -3.01 Million | -1.89 Million |
| Effect of forex changes on cash | 46.59 Thousand | 24.27 Thousand | 289.39 Thousand | 71.52 Thousand | 7744.00 | -257.64 Thousand |
| Net cash flow / Change in cash | 602.01 Thousand | -968.79 Thousand | -10.27 Million | 9.87 Million | -4 Million | -9.58 Million |
| Free Cash Flow | -11.51 Million | -10.82 Million | -16.99 Million | -7.15 Million | -11.41 Million | -15.12 Million |
| Breakdown | 2023 FY | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.86 Million | -2.71 Million | -2.71 Million | -26.52 Million | -8.67 Million | -9.61 Million |
| Depreciation & Amortization | 119.3 Thousand | 29.82 Thousand | 29.82 Thousand | 118.88 Thousand | 29.72 Thousand | 29.72 Thousand |
| Deferred income taxes | -99.84 Thousand | 11.61 Thousand | - | -10.32 Thousand | - | - |
| Stock-based compensation | 379.41 Thousand | 90.64 Thousand | 90.64 Thousand | 342.79 Thousand | - | 82.61 Thousand |
| Change in working capital | -4.24 Million | -206.51 Thousand | -206.51 Thousand | 3.55 Million | 207.32 Thousand | 207.32 Thousand |
| Other non-cash items | -3.79 Million | -1.06 Million | -1.06 Million | 13.83 Million | 6.89 Million | 7.74 Million |
| Investing Cash Flow | 1.44 Million | 120.00 | 120.00 | -2.14 Million | -304.13 Thousand | -304.13 Thousand |
| Investments in PPE | - | - | - | -2.14 Million | - | - |
| Acquisitions | 1.43 Million | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 10.04 Thousand | - | - | - | - | - |
| Other Investing Activities | 505.00 | 120.00 | 120.00 | 969.00 | -304.13 Thousand | -304.13 Thousand |
| Financing Cash Flow | 10.62 Million | 3.84 Million | 3.84 Million | 9.83 Million | 1.64 Million | 1.64 Million |
| Debt repayment | -1.45 Million | -2.63 Million | - | -114.25 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 5.89 Million | - | - | - | - |
| Other Financing Activities | -786.29 Thousand | 3.84 Million | 3.84 Million | 9.94 Million | 1.64 Million | 1.64 Million |
| Accounts receivables | 14.06 Thousand | -31.41 Thousand | -31.41 Thousand | -103.6 Thousand | - | - |
| Accounts payables | -14.06 Thousand | -3.19 Million | - | 103.6 Thousand | - | - |
| Inventory | -319.82 Thousand | -129.42 Thousand | -129.42 Thousand | 827.57 Thousand | 67.36 Thousand | 67.36 Thousand |
| Other working capital | -3.92 Million | -45.67 Thousand | -45.67 Thousand | 2.73 Million | 139.96 Thousand | 139.96 Thousand |
| Cash at beginning of period | 15.39 Thousand | 389.24 Thousand | - | 984.19 Thousand | - | 372.64 Thousand |
| Cash at end of period | 617.4 Thousand | 55.4 Thousand | 17.08 Thousand | 15.39 Thousand | -178.62 Thousand | 194.02 Thousand |
| Capital Expenditure | - | - | - | -2.14 Million | - | - |
| Effect of forex changes on cash | 46.59 Thousand | 25.2 Thousand | 25.2 Thousand | 24.27 Thousand | 30.21 Thousand | 30.21 Thousand |
| Net cash flow / Change in cash | 602.01 Thousand | -333.84 Thousand | 17.08 Thousand | -968.79 Thousand | -178.62 Thousand | -178.62 Thousand |
| Free Cash Flow | -11.51 Million | -3.85 Million | -3.85 Million | -10.82 Million | -1.54 Million | -1.54 Million |
NXM
VZLA
7277
BRU
LEG
UOS